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The reversible inhibition of acetylcholinesterase (AChE) by
4,4'-bipyridine (BP) was measured with acetylthiocholine as sub-
strate. The enzyme/inhibitor dissociation constant for binding of
BP to the catalytic site was Ka = 1.0 mM and the non-competitive
dissociation constant for binding to an allosteric site was K, =
= 9.0 mM.
BP protected AChE against phosphylation by sarin, soman,
tabun and VX. The protective effect was also calculated theoreti-
cally from a model which assumed that BP reacts either with
the catalytic site of the enzyme or with an allosteric site, but
does not form a ternary complex with acetylcholinesterase. The
calculated and experimentally determined protective indices agreed
well.
INTRODUCTION
The purpose of the study was to evaluate the type of reversible binding
of 4,4'-bipyridine (BP) to acetylcholinesterase (AChE). The evaluation was
done in a two-step approach. First, the inhibition of AChE by BP was measured
using different concentrations of BP and substrate (acetylthiocholine) where-
from the enzyme!inhibitor dissociation constants were determined. The second
step consisted in measuring the effect of BP upon phosphylation of AChE
by organophosphorous compounds (OP). This effect will depend upon the
binding sites of BP on the enzyme as laid out under Theoretical equations.
The OP compounds were sarin, soman, tabun and VX. The results obtained
were discussed in terms of which type of reversible binding would best
protect the enzyme against phosphylation.
EXPERIMENTAL
All experiments were done in 0.10 M phosphate buffer (NaH2P04/Na2HP04)
pH 7.4 at 37 DC. The enzyme activities were measured by the spectrophotometric
method of Ellman et al.'
The source of acetylcholinesterase (AChE; EC 3.1.1.7) was native human ery-
throcytes obtained from heparinized blood. The erythrocytes were washed twice
with 0.9 M NaCI and diluted with 0.9 M NaCl to the volu me of blood. The washed
erythrocytes (0.5 ml) were added into buffer (85 ml; 0.20 M buffer) and 1.50 ml of
the erythrocyte suspension was used per enzyme assay.
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4,4'-bipyridine (BP; Riedel - de Haen A. G., Seeize - Hannover, West Ger-
many). - Stock solutions (0.10 M) were prepared in 20% ethanol ; further dilutions
were made in water.
Organophosphorous compounds (OP). - The compounds are listed in Table 1.
Stock solutions (2.0 mg/ml or 4.0 mg/ml) were prepared in propylene glycol and
further diluted with water. The purity of the OP was about 97%.
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Ka = 1.0 mM




















CH3 ka = (7.2 ± 0.3) X 101
k, = (2.7 ± 0.1) X 101 (8)
ka = (2.0 ± 0.1) X 108 (9)
ka = (3.4 ± 0.2) X 101 (6)
VX
(4)
Ko, Ki: reversible enzyme/inhibitor dissociation constants (see schemes I-IV)
k,: second order rate constant of inhibition in absence of BP expressed in M-l min'
(see eqn. 1)
n: number of observations
Substrate. Stock solutions (0.10 M) of acetylthiocho1ine iodide were prepared in
water and further diluted with water.
DTNB. -- The thiol reagent 5,5'-dithiobis-(2-nitrobenzoic acid) was prepared
in buffer (stock solution 10 mM). The final concentration during enzyme assay was
0.33 mM.
Reversible inhibition by BP. - The reaction mixture contained 1.50 ml ery-
throcyte suspension, 100 ul DTNB, 0.30 ml BP, 0.80 ml water and 0.30 ml substrate.
The control samples contained 0.30 ml water instead of BP. The increase in absor-
bance was read in 1.0 cm cuvettes at 412 nm at 15 s intervals up to 2 min. The
first reading was done 15 s after the addition of substrate.
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Progressive inhibition by OP compounds. - The OP compound (0.30 ml) was
added to the reaction mixture whichcontained 1.50 ml erythrocyte suspension,
100 ul DTNB and 0.80 ml water. After a given time of inhibition the substrate
(0.30 ml) was added and the activity measured as described above. The control
samples contained 0.30 ml water instead of the OP compound. The final substrate
concentration was either 1.0 or 5.0 mM.
Effect of BP upon progressive inhibition by OP compounds. - The OP com-
pound (0.30 ml) was added to the reaction mixture which contained 1.50 ml ery-
throcyte suspension, 100 u.l DTNB, 0.30 ml BP and 0.50 ml water. After a given time
of inhibition the substrate was added and the activity measured as described above.
The control samples contained 0.30 ml water instead of the OP compound. The final
substrate concentration was as above.
All activiti es were measured against a blank which contained 1.50 ml erythro-
cyte suspension, 100 ul DTNB and 1.40 ml water. The activities of the enzyme pre-
paration (undiluted erythrocytes) were between 2 and 4 umol min'" (ml erythro-
cyte):'. During enzyme assay the increase in absorbance was linear with time in
both, inhibited and non-inhibited enzyme samples.
Non-enzymic substrate hydrolysis: The non-enzymic hydrolysis was measured
in the same way as the enzymic hydrolysis except that the reaction mixture eon-
tained 1.50 ml buffer (0.20 M) instead of the enzyme suspension. Corrections for the
non-enzymic hydrolysis were required only when substrate concentrations were
5.0 and 10 mM; BP increased only slightly the non-enzymic substrate hydrolysis.
THEORETICAL EQUATIONS FOR THE EFFECT OF A REVERSIBLE INHIBITOR UPON
PHOSPHYLATION
Four mechanisms are theoretically possible for the reaction of an enzyme













E + I!=; El
K,
E + I!=; lE
K,
El + I!=; lEI
Ka
IE + I!=; lEI
El and lE are enzyme/inhibitor complexes formed in the catalytic and an
allosteric site respectively, and lEI is a ternary complex. The above reaction
schemes are based upon theoretical considerations laid out earlier." The basic
assumption is the independence of the binding sites, i. e. the dissociation con-
stant for a given site has the same numerical value irrespective of whether
the other site is free or occupied. In Scheme I the reversible inhibitor binds
only to the catalytic site, in Scheme II only to the allosteric site, in Scheme III
the inhibitor can react either with the catalytic or with the allosteric site,
while in Scheme IV the inhibitor can also form a ternary complex by binding
to both sites simultaneously.
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If an OP compound reacts only with the free enzyme:
ka
E + OP --+ E - phosphylated (1)
the effect of the reversible inhibitor upon the rate of phosphylation will be
defined by one of the following equations:
Vo
Inv = (ka' op . t)/(1 + ilKa)
t
(2)
VIn _0_ = (ka' op . t)/(1 + ilKi)
Vt
(3)




In _0_ = (ka' op . t)/[(1 + ilKa) (1 + iIKi)]
Vt
(5)
Vo and Vt are the enzyme activities in the absence and in presence of the
inhibitor, ka is the second order rate constant of phosphylation in absence
of the reversible inhibitor, i is the concentration of the reversible inhibitor,
op is the concentration of OP, and t is the time of inhibition.
Equations (2) through (5) correspond to reaction Schemes I through IV.
The reversible inhibitor will protect the enzyme against phosphylation and
the protective efect will depend upon the ratio of ilKa and i/Ki. The pro-
tective effect can be expressed in terms of a protective index:
Protective index = PI = k)ka' (6)
where ka' is the second order rate constant of phosphylation in the presence
of the reversible inhibitor. Four expressions can be derived for the protective
indices corresponding to equations (2) through (5):
PI = 1 + ilKa (7)
PI = 1+ ilKi
PI = 1 + ilKa + ilKi




The protective indices in eqn. (6) can also be calculated from first order
rate constants (at a given OP concentration) instead of from ka and ka',
provided that phosphylation follows eqn. (1).
RESULTS AND DISCUSSION
The reversible inhibition of AChE by BP was evaluated over a concen-
tration range of BP from 1.0 to 9.0 mM, and over a range of acetylthiocholine
concentrations from 0.10 to 10 mM. At each substrate concentration 3-5 dif-
ferent BP concentrations were tested, and the obtained results are presented
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Figure 1. Reversible inhibition of AChE by BP. At each substrate concentration (s)
three to five different BPconcentrations were used. K,pp is the apparent enzyme/
linhibitor dissociation constant defined by eqn. (1'1). Each point is the mean value
of 11 experiments. The bars are S.E.M.
in Figure 1 using the Hunter-Downs plot. The ordinate on that plot represents
the apparent enzymelinhibitor dissociation constant
(11)
Vo and Vj are the enzyme activities in the absence and in the presence of
inhibitor, and i is the inhibitor (BP) concentration. The Hunter-Downs plot
was curved and this indicates that BP binds to two different sites on the
enzyme." An extrapolation of the curve to zero substrate concentration gives
the dissociation constant Ka for binding of BP to the catalytic site. This con-
stant was 1.0 mM obtained from graphic extrapolation. At substr ate concen-
trations between 5.0 and 10 mM the inhibition approached a plateau indicating
that BP was also a non-competitive inhibitor with respect to acetylthiocholine.
The non-competitive dissociation constant Kj of BP was 9.0 mM (mean value
of Kapp at 5.0 and 10 mM acetyltiocholine). No theoretical equation was derived
for the competition between BP and acetylthiocholine, however a qualitative
conclusion can be made about the mechanism of the reaction. BP did not
compete with acetylthiocholine at acetylthiocholine concentrations which in-
hibit the enzyme. This indicates that Kj cannot represent binding of BP to the
substrate-inhibition-site, but is likely to represent binding to another allosteric
site of acetylcholinesterase.
The effect of BP was also tested as protector again st phosphylation of
AChE by OP compounds. The OP compounds were sarin (40, 60 and 200 .uM),
soman (5.0 and 25 nM), tabun (50 and 100 nM) and VX (30, 60, 75 and 150 nM).
At each OP concentration the time course of inhibition was measured over
a period from zero up to 5 min. The BP concentrations covered a range which
corresponded from its Ka to its K, constant. The results of these measure-
ments were expressed in terms of protective indices (eqn. 6) and are listed
in Table II. The second order rate constants of inhibition in absence of the
reversible inhibitor are listed in Table 1. BP protected the enzyme against
r
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phosphylation, and the protection was better at higher BP concentrations.
At a given BP concentration the protective index was about the same irre-
spective of which OP compound was used as the phosphylating agent.
From a comparison between the experimentally determined (Table II)
and the theoretically calculated protective indices (Table III) it is possible to
assign the mechanism by which BP binds to acetylcholinesterase.
TABLE II
Effect of BP upon Phosphylation of AChE. The Protective Index was Obtained from
eqn. (6). ± is the S.E.M. The Number of Experiments is Given in Brackets
Protective index
OP Compound













10.9 ± 0.8 (6)
14.2 ± 0.9 (6)
11.8 ± 0.6 (6)
11.0 ± 1.0 (7)
TABLE III
Theoretically Calculated Protective Indices for the Effect of a Reversible Inhibitor
(I) upon Phosphylation of an Enzyme. The Protective Indices were Calculated from
eqns. (7) Through (10) Which Correspond to Reaction Schemes I Through IV Deiineti
in the Text. Protective Indices were Calculated from the Dissociation Constants
of BP Which are Ka = 1.0 mM and K. = 9.0 mM
Proteetive Index
Seh eme (Eqn.)
[I] = 1.0 mM [I] = 3.3 mM [I] = 10.0 mM
Seh eme I (7) 2.00 4.30 11.0
Scheme II (8) 1.11 1.37 2.11
Scheme III (9) 2.11 4.67 12.1
Seh eme IV (10) 2.22 5.88 23.2
Schemes I and II described under Theoretical equations can be ruled out
for the reaction of BP with AChE, because the results obtained from rever-
sible inhibition have shown that BP must have two binding sites for the
enzyme (Figure 1). It is however of interest to note that eqns. (7) and (8), which
are based upon Schemes I and II, are mathematically identical. This means
that for a given ratio of ilKa or ilKi the protective index will be the same
irrespective of which mechanism holds good. In a previous study these two
schemes were verified experimentally for the effect of several reversible
ligands (tetramethylammonium, edrophonium, coumarin) upon phosphylation
of AChE by VX.3
Schemes III and IV each assume that the enzyme has two binding sites
for the reversible inhibitor. Furthermore, these two schemes can be well
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distinguished from each other at inhibitor concentrations which approach the
Ki constant (Table III). At 10 mM BP the theoretical protective index should
be 12.1 if Scheme III holds, and 23.2 if Scheme IV holds. The experimental1y
obtained protective index at 10 mM BP was 12.0 (mean value obtained with
four OP compounds; Table II). Consequently, it seems that BP reacts according
to Scheme III. This would mean that BP binds either to the catalytic site El,
or to an allosteric site lE, but does not form a ternary complex lEI with
AChE. Reversible inhibitors which form ternary complexes (Scheme IV) would
provide a better protection against phosphylation.
Finally, a comparison between Schemes I and III can show that the
second binding site of BP (Ki = 9.0 mM) contributes only little to the pro-
tection of AChE against phosphylation. If BP had only one binding site
(Scheme I; Ka = 1.0 mM) its protection against phosphylation would be about
the same as it is now with two binding sites (Ka and Ki) (compare ca1culated
protective index for schemes I and III in Table III). The contribution of the
second binding site would become more apparent only at BP concentrations
much higher than Ki.
The described approach of verifying or establishing binding sites for
ligands has so far been applied only to compounds which reversibly bind to
one site on the enzyme (ef. 3). In the present study this approach has been
extended to a ligand which has two binding sites for acetylcholinesterase.
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SAŽETAK
Inhibicija acetilkolinesteraze 4,4'-bipiridinom i njegov utjecaj na fosfiliranjeenzima
Elsa Reiner
Reverzibilna inhibicija acetilkolinesteraze u 4,4'bipiridinom (BP) mjerena je
s acetiltiokolinom kao supstratom. Konstanta disocijacije za kompleks u katalitič-
kom mjestu enzima iznosila je Ka = 1,0mM, a za nekompetitivno vezanje u aloste-
ričkom mjestu Ki = 9,0 mM.
BP je štitio enzim od fosfoniliranja sarinom, somanom, tabunom i VX-om.
Protektivni učinak je i teorijski proračunan prema modelu koji pretpostavlja da se
BP veže ili u katalitičkom mjestu enzima ili u alosteričkorn mjestu enzima, ali ne
stvara ternarni kompleks s enzimom. Eksperimentalni i proračunani protektivni
učinci dobro se slažu.
